You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠集團(000513.SZ):獲得阿塞那平透皮貼劑若干知識產權下的獨家、包含特許權使用費、可轉授權的許可權
格隆匯 07-03 17:44

格隆匯 7 月 3日丨麗珠集團(000513.SZ)公佈,公司於2020年7月3日與LTS Lohmann Therapie-Systeme AG(“LTS”)簽署了《授權合作協議》,LTS將授予公司阿塞那平透皮貼劑(“授權產品”)若干知識產權下的獨家、包含特許權使用費、可轉授權的許可權。根據協議約定,公司將與LTS合作開發授權產品,授權產品上市後公司將擁有其在中國大陸、香港特別行政區及澳門特別行政區,不含台灣地區(“授權區域”)的獨家商業化權利。另,公司需支付授權產品在研發、申報及上市後各階段相應的費用、里程碑金及銷售提成。

經友好協商,雙方達成的協議包括如下條款:授權產品:阿塞那平透皮貼劑,用於治療精神分裂症。授權區域:中國大陸、香港特別行政區及澳門特別行政區,不含台灣地區。

此次合作旨在發揮LTS在透皮技術領域研發優勢及公司在授權區域內商業化運營優勢,以實現互利共贏、共同發展的最終目標。此次合作將進一步拓展公司在精神神經領域的產品管線佈局,亦將進一步探索高端複雜製劑技術,不斷開發出國際及國內領先的創新藥品,符合公司中長期創新藥發展的戰略佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account